Post-castration Drug Therapy in Prostate Cancer Patients
A new study concludes that men treated with the drug flutamide after surgical castration for advanced metastatic prostate cancer have poorer qualities of life, compared to patients not taking the drug.
* researchers at the Fred Hutchinson Cancer Research Center, in Seattle, Washington, studied more than 700 prostate cancer who were castrated to reduce testosterone levels to collect data.
* found that those patients post-operatively treated with flutamide reported higher levels of diarrhea and mental health problems after three months, compared to patients taking a placebo.
* authors further note that, in agreement with another recently- published study, no survival benefit was found among those treated with the drug after castration, compared to those given a placebo.
Posted in: Prostate Cancer
